TY - JOUR
AU - 
AB - Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 J. Pillonel and 2003 and impact of Nucleic Acid Testing (NAT) 12, rue du Val d’Osne - 94415 St-Maurice Cedex - FRANCE Tél. : 33 (0)1 41 79 67 47 Fax : 33 (0)1 41 79 67 66 j.pillonel@invs.sante.fr 1 2 J. Pillonel , S. Laperche et l'Etablissement français du sang MoPeC3573 1 2 Institut de veille sanitaire, Saint-Maurice, France. Institut national de la transfusion sanguine, Paris, France. Table 2. Residual risk (RR) of transfusion-transmitted viral infections in France Background 1992-94 1995-97 1998-00 2001-03* p Monitoring trends in residual risk of transfusion-transmitted viral infections is important HIV 1.68 0.82 0.73 0.32 RR p.10 0.1 to assess improvements in blood safety and to adapt the reduction risk policies. (95% CI) (0.3-4.4) (0.1-2.4) (0.1-2.1) (0.0-1.1) These trends were analysed over 10 overlapping periods of 3 years from 1992 to 2003. HCV 4.59 3.61 1.16 0.10 -3 RR p.10 <10 (95% CI) (1.4-12) (1.3-7.9) (0.3-3.3) (0.0-0.8) The 2001-03 estimates were compared to the results of HIV-1 and HCV NAT implemented on all blood donations in July 2001. HBV 8.87 4.94 1.81 1.57 RR p.10 -4 <10 (95% CI) 
TI - Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)
JO - Eurosurveillance
DO - 10.2807/esm.10.02.00519-en
DA - 2005-02-01
UR - https://www.deepdyve.com/lp/unpaywall/trends-in-risk-of-transfusion-transmitted-viral-infections-hiv-hcv-hbv-Nmw2Rdea30
DP - DeepDyve
ER -